Ocular Therapeutix
OCUL
#3979
Rank
โ‚น264.11 B
Marketcap
โ‚น1,240
Share price
-4.66%
Change (1 day)
62.57%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2025 (TTM): -โ‚น21.61 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are โ‚น55.78 Million. In 2024 the company made an earning of -โ‚น17.49 Billion a decrease over its 2023 earnings that were of -โ‚น7.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น21.61 Billion23.57%
2024 -โ‚น17.49 Billion139.68%
2023 -โ‚น7.3 Billion13.65%
2022 -โ‚น6.42 Billion984.05%
2021 -โ‚น0.6 Billion-95.79%
2020 -โ‚น14.07 Billion80.19%
2019 -โ‚น7.81 Billion44.01%
2018 -โ‚น5.42 Billion-5.38%
2017 -โ‚น5.73 Billion41.79%
2016 -โ‚น4.04 Billion12.47%
2015 -โ‚น3.6 Billion38.75%
2014 -โ‚น2.59 Billion115.12%
2013 -โ‚น1.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Intersect ENT
XENT
-โ‚น14.58 Billion-35.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
โ‚น1.17 B-105.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น21.93 B-197.22%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
-โ‚น1.02 Billion-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA